Israel’s OurCrowd ties up with WHO Foundation for $200 mn health fund

 Israel’s OurCrowd ties up with WHO Foundation for $200 mn health fund

OurCrowd, one of Israel’s most prolific venture capital firms, has raised a $200 million investment vehicle in collaboration with the WHO Foundation.

The Global Health Equity Fund (GHEF) will be a financial first-impact venture capital fund which will focus on breakthrough technology solutions that can impact healthcare globally.

OurCrowd said the fund was conceived after the Covid-19 pandemic that crippled the global health system. It said the fund will focus on healthcare and the industries that are direct determinants of health, including energy transition and food agriculture.

The new fund will be led by OurCrowd CEO, Jon Medved, and OurCrowd Managing Partner, Dr. Morris Laster, with the support of the WHO Foundation’s Chief Impact Investment Officer, Geetha Tharmaratnam. It will be managed by an OurCrowd team of clinical experts with decades of experience in medical technologies and startup growth.

The firm said that the target portfolio companies will not only innovate to improve medical care but will also work to mitigate current global health risks related to climate, fossil fuels, and looming food shortages.

“Covid-19 was a wake-up call for me as an investor,” said Medved. “The pandemic opened my eyes to health inequity around the world and reinforced the potential of innovative technology to save lives.

“The collaboration with the WHO Foundation will allow us to identify even more exciting investments and facilitate the commitment of investors and entrepreneurs to equitable access to the technologies we support.”

Aman Malik

error: Content is protected !!
The Capital Quest